Skip to content

Pharmaceutical Development Group (PDG) is a subsidiary of Biotech Research Group Corporation.

+1.813.333.2950 info@pharmdevgroup.com
PDG
Pharmaceutical Development Group
PDG PDG
  • Home
  • Services
    • Pharmaceutical Consulting Services
    • Strategic Drug Development
      • Strategic Drug Development Services
      • Pharmaceutical Development Programs: Implementation and Oversight
      • Pre-IND Meetings
      • Investigational New Drug Application (IND)/Special Protocol Assessment (SPA)
      • Clinical Trial Design
      • Pre-NDA Meetings and NDA Submissions: 505(b)(1)/505(b)(2)
      • 505(b)(2) NDAs
      • Generic Drugs: 505(j) ANDAs and Potential Diversification
      • Nonprescription Drugs (OTC)
    • Medical Device Consulting
      • Exempt Devices / 513(g) Submissions
      • Device Pre-submission Meetings and Reviews
      • Facility Inspection Readiness
      • Combination Device and Drug/Biologic Submissions
      • 510(k) Submissions
      • PMA Submissions
    • Post-Launch Activities
      • Drug Post-Launch Activities
      • Post-Marketing Surveillance
      • Drug Labeling
    • Specialty Services
      • Specialty Services
      • Citizen Petitions
      • Legal Support
      • Literature Searches
      • Pharmacokinetic Consulting
      • Quality Assurance & Compliance
      • Scientific and Technical Writing
      • Supplier/Vendor Selection and Qualification
      • Toxicology Consulting
  • Regulatory Updates
  • About PDG
    • About PDG – An FDA Regulatory Consultant
    • Your Pharmaceutical Consultant
    • Careers at PDG
  • Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
  • Contact PDG
  • Home
  • Services
    • Pharmaceutical Consulting Services
    • Strategic Drug Development
      • Strategic Drug Development Services
      • Pharmaceutical Development Programs: Implementation and Oversight
      • Pre-IND Meetings
      • Investigational New Drug Application (IND)/Special Protocol Assessment (SPA)
      • Clinical Trial Design
      • Pre-NDA Meetings and NDA Submissions: 505(b)(1)/505(b)(2)
      • 505(b)(2) NDAs
      • Generic Drugs: 505(j) ANDAs and Potential Diversification
      • Nonprescription Drugs (OTC)
    • Medical Device Consulting
      • Exempt Devices / 513(g) Submissions
      • Device Pre-submission Meetings and Reviews
      • Facility Inspection Readiness
      • Combination Device and Drug/Biologic Submissions
      • 510(k) Submissions
      • PMA Submissions
    • Post-Launch Activities
      • Drug Post-Launch Activities
      • Post-Marketing Surveillance
      • Drug Labeling
    • Specialty Services
      • Specialty Services
      • Citizen Petitions
      • Legal Support
      • Literature Searches
      • Pharmacokinetic Consulting
      • Quality Assurance & Compliance
      • Scientific and Technical Writing
      • Supplier/Vendor Selection and Qualification
      • Toxicology Consulting
  • Regulatory Updates
  • About PDG
    • About PDG – An FDA Regulatory Consultant
    • Your Pharmaceutical Consultant
    • Careers at PDG
  • Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
  • Contact PDG

Yearly Archives: 2021

You are here:
  1. Home
  2. 2021

Pharmaceutical regulatory consulting

How to choose Pharmaceutical regulatory consulting services?

Other BlogBy Third-Party ContributorApril 12, 2021

When your pharmaceutical company is working on a new project to develop new medicines, in this scenario, all they need is to take help from the pharmaceutical regulatory consulting company so that the project cannot face any burdens at this precious time. So, whenever you are choosing a pharmaceutical regulatory company that will help you…

qtq80-LZe7yw

Important factors that are needed to be considered for 510(k) submissions

Other Blog, Other BlogBy Third-Party ContributorApril 5, 2021

While working in the fields of medicine, getting certification is the much-needed thing that should be taken care of. In order to obtain certificates from the company, it is needed to have and follow some rules so that you will be able to gain the best results from the end of the service provider. Similarly,…

Pharmaceutical Industry News

Pharmaceutical Industry News – Keep You update About Pharma Industry

Other BlogBy Third-Party ContributorJanuary 12, 2021

The news regardless of the topic, the day, the place where you live; they have great importance for people’s lives, it is given by the set of communication media that inform us about the most outstanding events. Thanks to the news we can know which route to take towards our work, know when it is…

505(b)(2) nda

Know about the 505(b) (2) and its benefits

Other BlogBy Third-Party ContributorJanuary 7, 2021

The 505 (b) (2) application is one of three established types of regulatory submissions and may favor pharmaceutical sponsors. The FFDC defines the statutory submission of 505 (b) (2) as an NDA that includes a safety and efficacy investigation, most of which requires applicants to approve such an NDA. An applicant who is an applicant…

Drug Vendor Selection

Drug Supplier Selection – Choosing a Good Drug Supplier

Other BlogBy Third-Party ContributorJanuary 2, 2021

Not all inputs or raw materials have the same importance, and depending on specific needs, each company may emphasize certain standards and not others. According to your needs it is must to have good Drug supplier selection. But in addition to this, having the right suppliers allows you to have certain control over production costs…

By Keyword
505B2 510K ANDA biologics biologics-device cbe Citizen Petition Clinical Trial Design combination products drug-device drug development FDA Announcement FDA Compliance FDA Consultants FDA Consulting FDA Presentation FDA Regulations FDA Regulatory Affairs Final Monograph Florida RAPS generic Generic Drug Labeling Generic Drug Submissions Labeling Compliance medical device NDA NDA Consultants OPDP Consulting OTC OTC Monograph Pharmaceutical Consultants Pharmaceutical Consulting Pharmaceutical Legislation Pharmacovigilance Prescription Drugs Prescription to OTC RAPS Regulatory Affairs Professional Society Regulatory affairs services Regulatory consultant regulatory path Rx to OTC TFM Unapproved Drugs User Fees
Fill Your Details Here.






    captcha

    Pharmaceutical Development Group

    PDG® is a federally registered service mark of Pharmaceutical Development Group, Inc.Pharmaceutical Development Group (PDG) is a subsidiary of Biotech Research Group Corporation.

    Service
    • Strategic Drug Development
    • Medical Device Consulting
    • Post-Launch Activities
    • Specialty Services
    Regulatory Updates
    • Labeling / Marketing
    • Medical Device Consulting News
    • Pharmaceutical Consulting News
    • Quality Assurance & Compliance
    • Regulatory Affairs
    • Research & Development
    • Safety & Pharmacovigilance
    • Submissions
    Regulatory Resources
    • Regulatory Resources
    • FDA Links
    • International Health Authority’s Websites
    • About PDG
    • Contact
    ©2019. Pharmaceutical Development Group, Inc. All Rights Reserved.
    • Privacy
    • Terms of Use
    • Careers at PDG
    • Blog
    • Site Map
    Footer Menu
    Go to Top